Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Acalabrutinib 💬
(Acalabrutinib (JAN/USAN/INN))
[1] Acalabrutinib (Acalabrutinib maleate monohydrate)[1] Acalabrutinib[1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 46, 61 💬
2 Acalabrutinib maleate hydrate 💬
(Acalabrutinib maleate hydrate (JAN), Acalabrutinib maleate monohydrate)
[1] Acalabrutinib (Acalabrutinib maleate monohydrate)[1] Acalabrutinib[1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 46, 61 💬